Skip to content
WeighLab
Menu
Ranked #418 · Grade C

MyStart Health review

MyStart Health is a cash-pay GLP-1 telehealth program priced at a single blended $299/month rate covering physician evaluations, unlimited clinician follow-ups, a 4-week or 12-week medication supply, bloodwork, and shipping.

Visit MyStart Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$299/mo (compounded)
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$3,588

Pricing verified August 2026

The Index scorecard

MyStart Health scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month35/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options53/100
Clinical Oversight78/100
Contract Flexibility31/100

Where the value is

  • Genuinely all-inclusive stated price: physician evaluations, unlimited follow-ups, bloodwork, and shipping are explicitly bundled into the $299 figure with 'no hidden fees'
  • Price-lock guarantee explicitly covers dose increases — the FAQ states the price won't rise 'even if your dosage increases'
  • Named Chief Medical Advisor (Dr. Ritu Chopra, Beverly Hills MD)
  • Clear, simple cancellation process via email with confirmation

The tradeoffs

  • Does not publish separate pricing for semaglutide vs. tirzepatide — $299 is a single blended program price, so it's unclear which drug (or whether both) that figure actually buys
  • A sitewide 'Lifetime 25% Off' promo banner is not reconciled against the stated '$299/month excluding any discounts' base price or the price-lock guarantee's 'excluding our first-time discount' exception — genuinely ambiguous what a patient ends up paying long-term
  • No compounding pharmacy named, only generic 'US facilities that meet strict USP standards'
  • No state-coverage list and no LegitScript certification found anywhere on the site
  • FDA issued Matthew Stern, CEO MyStart Health LLC. a warning letter in September 2025; the letter is public in FDA's warning-letter database

The bottom line

Best for: Shoppers who want a single flat all-inclusive monthly price and don't need semaglutide vs. tirzepatide broken out separately. MyStart Health is a cash-pay GLP-1 telehealth program priced at a single blended $299/month rate covering physician evaluations, unlimited clinician follow-ups, a 4-week or 12-week medication supply, bloodwork, and shipping.

Ranked #418 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to MyStart Health.

The 24 programs nearest this one

Pricing, states and verification reflect MyStart Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on MyStart Health's site. Not medical advice; see our disclosure.

← Back to the value leaderboard